Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-006227-12Phase 3Completed
Phase 3, randomised trial in status asthmaticus and asthma comparing Nebulised magnesium sulphate + standard therapy with Placebo + standard therapy (2 arms). Primary endpoint: Yung Asthma Severity Score at 60 minutes. Started Feb 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-006227-12.